Study of SPARC1103 in Subjects With Spasticity

• Status: Completed
• Trial end date: 2017-04-28
• Target enrollment: 0
• Participant gender: All

Summary

Study of SPARC1103 in subjects with spasticity

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sun Pharma Advanced Research Company Limited

Criteria

Inclusion Criteria:

• Men and women greater than or equal to 18 years of age

• Willing to sign the informed consent form

• Women of child bearing potential willing to practice an acceptable method of birth control

• Known history of spasticity due to MS

Exclusion Criteria:

• Administration of an investigational drug or device within 30 days prior to Screening Visit 1

• Unable to comply with trial procedures in the opinion of the Investigator

• Concomitant neurologic conditions causing spasticity

• Any medical condition, including psychiatric disease or epilepsy, which would interfere with the interpretation of the trial results